US 2014/0212414 A1Published application

Combination therapy using p53 activator and c-met inhibitor

AssigneeSamsung Electronics Co., Ltd.

InventorsYoung Mi OH, Kyung Ah Kim

Life of this patent

Estimating the term…

A method of preventing and/or treating a cancer comprising co-administering a p53 activator and a c-Met inhibitor to a patient in need thereof.

Dependent claims

A method of preventing or treating a cancer comprising co-administering a p53 activator and a c-Met inhibitor, to a patient in need thereof.

Dependencies are inferred from the claim text.

A61K 31/496
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: non-condensed piperazines…
A61K 31/122
Ketones: having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 31/497
Non-condensed pyrazines: containing further heterocyclic rings
A61K 39/39558
Against materials from animals: against tumor tissues, cells, antigens

From the US filing history. Foreign family members aren’t listed.

Loading patent…